Trial Profile
Phase IV: Treatment of Chronic Insomnia in Patients With Breast Cancer Following Completion of Chemotherapy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2011
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 28 Jan 2009 Actual number of patients (16) added as reported by ClinicalTrials.gov.
- 28 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 28 Jan 2009 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.